Intellectual Property India Publishes Patent Application for 'Genetically Modified Mice Expressing Components Of Human Cellular Immune System' Filed by Regeneron Pharmaceuticals, Inc.

MUMBAI, India, April 25 -- Intellectual Property India has published a patent application (202517033120 A) filed by Regeneron Pharmaceuticals, Inc., Tarrytown, U.S.A., on April 3, for 'genetically modified mice expressing components of human cellular immune system.'

Inventor(s) include Tu, Naxin; Mcwhirter, John; Guo, Chunguang; Gurer, Cagan; Voronina, Vera; Macdonald, Lynn; and Murphy, Andrew J.

The application for the patent was published on April 25, under issue no. 17/2025.

According to the abstract released by the Intellectual Property India: "Disclosed herein are non-human animals (e.g., rodents, e.g., mice or rats) genetically engineered to express a humanized or human T cell receptor (TCR) comprising a variable domain encoded by ...